The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition
Open accessAbstract
The chromosomal radiosensitivity of breast cancer patients with a known or putative genetic predisposition was investigated and compared to a group of healthy women. The chromosomal radiosensitivity was assessed with the G2 and the G0-micronucleus assay. For the G2 assay lymphocytes were irradiated in vitro with a dose of 0.4 Gy (60)Co gamma-rays after 71 h incubation, and chromatid breaks were scored in 50 metaphases. For the micronucleus assay lymphocytes were exposed in vitro to 3.5 Gy (60)Co gamma-rays at a high dose rate or low dose rate. 70 h post-irradiation cultures were arrested and micronuclei were scored in 1000 binucleate cells. The results demonstrated that the group of breast cancer patients with a known or putative genetic predisposition was on the average more radiosensitive than a population of healthy women, and this with the G2 as well as with the high dose rate and low dose rate micronucleus assay. With the G2 assay 43% of the patients were found to be radiosensitive. A higher proportion of the patients were radiosensitive with the micronucleus assay (45% with high dose rate and 61% with low dose rate). No correlation was found between the G2 and the G0-micronucleus chromosomal radiosensitivity. Out of the different subgroups considered, the group of the young breast cancer patients without family history showed the highest percentage of radiosensitive cases in the G2 (50%) as well as in the micronucleus assay (75-78%).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The hypothesis that BRCA mutation is associated with increased radio sensitivity was supported by experimental and clinical data [12-19].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [12]
In the citing paper
“Several studies suggest that BRCA gene mutation might influence response to radiation therapy because tumours in BRCA1/BRCA2 carriers are more sensitive to ionising radiation [5-12].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takata, M., Sasaki, M. S., Sonoda, E., Morrison, C., Hashimoto, M., Utsumi, H., Yamaguchi‐Iwai, Y., Shinohara, A., & Takeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5497 · Cited by 1,229 · cited 3×
“…are essentially the result of misrepaired dsb (Wu et al, 1996; Boei et al, 2000; Fomina et al, 2000) by the NHEJ repair system (Jeggo, 1998; Takata et al, 1998; Rothkamm et al, 2001), the mechanisms involved in the formation of G2 chromatid breaks are not fully understood yet and different…”
BackgroundEstimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,057 · cited 1×
“Breast cancer is the most common type of cancer in females, accounting for approximately 18% of all cancer cases in women worldwide (Parkin et al, 1988).”
BackgroundFenech, M. F. (1993) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(93)90049-l · Cited by 985 · cited 2×
“Per slide 500 binucleate cells (BN) were scored (light microscopy, 4006) according to the criteria of Fenech (1993).”
MethodPrevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D., Evans, C., Deacon, J., & Stratton, M. R. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 909 · cited 10×
“For further analysis we considered three subgroups in our total group of breast cancer patients: (1) a subgroup of patients that met criteria 1 and 2 (see Materials and Methods) and in which a mutation in BRCA1/2 was detected (BRCA1, n=4; BRCA2, n=7); (2) a subgroup of patients that met criteria 1 and 2 but without a…”
BackgroundInfluentialMolecular mechanisms of DNA double-strand break repair
Kanaar, R., Hoeijmakers, J. H. J., & van Gent, D. C. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01383-x · Cited by 527 · cited 4×
“Although recent studies have shown that G0/G1 chromosomal aberrations are essentially the result of misrepaired dsb (Wu et al, 1996; Boei et al, 2000; Fomina et al, 2000) by the NHEJ repair system (Jeggo, 1998; Takata et al, 1998; Rothkamm et al, 2001), the mechanisms involved in the formation of G2 chromatid breaks a…”
BackgroundInfluentialIdentification of Genes Involved in Repair of DNA Double-Strand Breaks in Mammalian Cells
Jeggo, P. A. (1998) · Radiation Research · doi:10.2307/3579810 · Cited by 283 · cited 1×
“…aberrations are essentially the result of misrepaired dsb (Wu et al, 1996; Boei et al, 2000; Fomina et al, 2000) by the NHEJ repair system (Jeggo, 1998; Takata et al, 1998; Rothkamm et al, 2001), the mechanisms involved in the formation of G2 chromatid breaks are not fully understood yet…”
BackgroundBRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen, J. J., Silver, D. P., Cantor, S., Livingston, D. M., & Scully, R. (1999) · PubMed · Cited by 217
Rothfuß, A., Schütz, P., Bochum, S., Volm, T., Eberhardt, E., Kreienberg, R., Vogel, W., & Speit, G. (2000) · PubMed · Cited by 212
Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays
Scott, D. A. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099140744 · Cited by 209 · cited 12×
“Apart from the population characteristics, differences in the MN assay protocols may also be responsible for the differences between the results of Scott et al (1998, 1999) and present work.”
BackgroundMethodResultInfluentialDouble-Strand Break Repair Deficiency and Radiation Sensitivity in BRCA2 Mutant Cancer Cells
Abbott, D. W., Holt, J. T., & Freeman, M. L. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.978 · Cited by 206 · cited 1×
“The exact role of BRCA1 and BRCA2 in repair of DNA damage by ionising radiation is not yet fully understood (Abbott et al, 1998; Wang et al, 2001).”
Background
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–136 of 136
Mayo, T., Schuster, B., Ellmann, A., Schmidt, M., Fietkau, R., & Distel, L. V. (2019) · OBM Genetics · doi:10.21926/obm.genet.1902082 · Cited by 6
Becker, A. A., Graeser, M., Landwehr, C., Hilger, T., Baus, W. W., Wappenschmidt, B., Meindl, A., Weber, R. G., & Schmutzler, R. K. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2119-0 · Cited by 5
Mozdarani, H., Mashhadi, A. H. Z., & Alimohammadi, Z. (2011) · Iranian Journal of radiation research/Iranian journal of radiation research · Cited by 5
Baeyens, A., Herd, O., Francies, F. Z., Cairns, A., Katzman, G., Murdoch, M., Padiachy, D., Morford, M., Vral, A., & Slabbert, J. P. (2015) · Mutagenesis · doi:10.1093/mutage/gev072 · Cited by 5
Self-citationCadwell, K. K., Whitehouse, C. A., Tarone, R. E., & Tawn, E. J. (2008) · Journal of Radiological Protection · doi:10.1088/0952-4746/28/1/n01 · Cited by 5
Seymour, C. B., Mothersill, C. E., & Moriarty, M. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601188 · Cited by 5
“The paper by Baeyens et al (2002) is interesting and we would like to contribute to the discussion.”
BackgroundBryant, P. E., Riches, A., Shovman, O., Dewar, J. A., & Adamson, D. J. A. (2012) · Mutagenesis · doi:10.1093/mutage/ges040 · Cited by 4
Francies, F. Z., Herd, O., Muller, X., Cairns, A., Murdoch, M., Nietz, M., Slabbert, J. P., & Baeyens, A. (2015) · South African Medical Journal · doi:10.7196/samjnew.8266 · Cited by 4
Self-citationThe prostate cancer risk locus at 10q11 is associated with DNA repair capacity
Rinckleb, A. E., Surowy, H., Luedeke, M., Varga, D., Schrader, M. G., Hoegel, J. J., Vogel, W., & Maier, C. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.05.003 · Cited by 4
Influence of intrinsic radiosensitivity on the survival of breast cancer patients
Roberts, S. A., Levine, E. L., & Scott, D. (2003) · International Journal of Radiation Biology · doi:10.1080/0955300031000137797 · Cited by 4
Intra-individual variation in G2 chromosomal radiosensitivity
Curwen, G. B., Cadwell, K. K., Tawn, E. J., Winther, J. F., & Boice, J. D. (2012) · Mutagenesis · doi:10.1093/mutage/ges006 · Cited by 3
Lymph node status as a prognostic factor in BRCA-positive breast cancer
Lee, J., Park, H. Y., Jung, J. H., Kim, W. W., Chae, Y. S., Lee, S. J., Lee, S., & Bae, Y. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.03.065 · Cited by 4
Ibelli, T. J., Chennareddy, S., Mandelbaum, M. G., & Henderson, P. W. (2023) · PubMed Central · Cited by 2
Mozdarani, H., Mozdarani, S., Pakniyat, F., Mozdarani, S., & Nosrati, H. (2025) · International Journal of Radiation Research · doi:10.61186/ijrr.23.1.37 · Cited by 2
Perletti (2008) · Molecular Medicine Reports · doi:10.3892/mmr_00000032 · Cited by 2
Hu, J. J., Hill, J. W., & Hu, J. J. (2009) · Cancer Management and Research · doi:10.2147/cmr.s4548 · Cited by 2
Chromosomal radiosensitivity of triple negative breast cancer patients
Francies, F. Z., Herd, O., Cairns, A., Nietz, S., Murdoch, M., Slabbert, J. P., Claes, K., Vral, A., & Baeyens, A. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1649502 · Cited by 2
“Based on previous in vitro studies (Scott et al. 1999; Baeyens et al. 2002), the total sample size for our study cohort was set to 100 breast cancer patients.”
BackgroundSelf-citationPredictive Biomarkers of Cellular Radiosensitivity for Clinical Radiotherapy Treatment
White, L. (2016) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/d70w2x · Cited by 2
Evaluation of predictive biomarkers for late radiation toxicity in breast cancer patients
Solana-Peña, Á., Pujol-Canadell, M., Garau, M. M., Martinez, E., Linares, I., Stefanović, M., Pérez-Montero, H., González-Viguera, J., Peñacoba, M. A., Ventura, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31033-x · Cited by 2
“These results are consistent with other studies indicating that cancer patients often exhibit higher frequencies of chromosomal aberrations in G0 lymphocytes after irradiation compared with healthy individuals 25,29,30 ..”
Chromosomal damage in breast cancer patients undergoing different radiotherapy schemes
Dayal, R., Ramadan, L., Veldeman, L., Murillo, C., Vandenputte, M., Pauw, T. D., Płódowska, M., Lisowska, H., Węgierek-Ciuk, A., Braziewicz, J., et al. (2026) · International Journal of Radiation Biology · doi:10.1080/09553002.2026.2636304 · Cited by 1
Self-citationDNA repair genes BRCA1 and DNA-PKcs have great potential in radiation therapy
Jiao, Y., Xu, X., & Hao, Y. (2012) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-012-1088-4 · Cited by 1
Barrera, L. M., Ortiz, L. D., Romero, H. G., Rojas, M., & Camargo, M. (2018) · Biomédica · doi:10.7705/biomedica.v38i4.3882 · Cited by 1
G₂ chromosomal radiosensitivity in childhood and adolescent cancer survivors and their offspring
Curwen, G. B. (2008) · St Andrews Research Repository (St Andrews Research Repository) · Cited by 1
The BRCA breast cancer patient: Treat the tumor or the problem?
Zippel, D. B., & Papa, M. Z. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21000 · Cited by 1
A role for topoisomerase II alpha in chromosome damage in human cell lines
Terry, S. Y. A. (2010) · St Andrews Research Repository (St Andrews Research Repository)
In Vitro Chromosomal Radiosensitivity and CellCycle Progression in Cancer Survivors
Cadwell, K. K. (2009) · CLOK (University of Central Lancashire)
Chromosomal radiosensitivity in South African breast cancer patients before and after radiotherapy
Muller, X. (2013) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Trombetta, M. G., Kotinsley, K., & Julian, T. B. (2011) · Journal of Radiotherapy in Practice · doi:10.1017/s1460396911000021
Counseling the Cancer Survivor
Jacobs, L. A., & Giarelli, E. (2006) · Elsevier eBooks · doi:10.1016/b978-012088393-6/50099-3
Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer
Moran, M. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-59198-8_9
Abberant Lymphocytes Rate after Gamma-Irradiationn as a Biomarker of Breast Cancer
Mojtahedi, F., Pooladi, A., Sirati, F., Kaihani, E., Akhlaghpour, S., Karimlou, M., Bagherizadeh, I., Fallah, M., Firouzabadi, S. G., & Behjati, F. (2016) · Sarem Journal of Reproductive Medicine · doi:10.29252/sjrm.1.3.89
Golfam, F., Hashemi, B., Haeri, A., & Nikoofar, A. (2019) · Journal of Biomedical Physics and Engineering · doi:10.31661/jbpe.v0i0.657
Yararbaş, K., Sayar, C., Tavukcu, C., Korkmaz, T., Cankaya, D., Karabacak, E., & Özbek, U. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0070
DNA damage in thyroid cancer patients treated with radioactive iodine in Johannesburg, South Africa
Kagodora, S. B., Baeyens, A., Vral, A., & Vangu, M. D. T. W. (2026) · EJNMMI Reports · doi:10.1186/s41824-026-00327-2
“Sub-sequently, this radiation sensitivity became evident in many cancer patients, including those with head and neck cancer, colorectal cancer, prostate cancer, lung cancer, and breast cancer (Ruyck et al. 2008; Riches et al. 2001; Baeyens et al. 2002).”
Self-citation
Metadata
- Authors
- Baeyens, A., Thierens, H., Claes, K., Poppe, B., Messiaen, L., De Ridder, L., & Vral, A.
- Affiliations
- Ghent University (BE)
- Corresponding author
- Vral, A
- Venue
- British Journal of Cancer
- Published
- 2002-11-26
- Volume
- 87
- Issue
- 12
- Pages
- 1379-1385
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2376291
- OpenAlex
- W2073895085
- Cited by
- 136
- References
- 38
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 6
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- chromosomal radiosensitivity, breast cancer, genetic susceptibility, family history (medicine), micronucleus test, chromatid breaks, lymphocytes, gamma irradiation, dose rate, young patients
- MeSH terms
- Adult, Aged, Breast Neoplasms, Chromosome Aberrations, Female, Gamma Rays, Humans, Lymphocytes, Middle Aged, Mutation, Radiation Tolerance, X-Rays, Micronucleus Tests, Resting Phase, Cell Cycle, G2 Phase, BRCA1 Protein, Genetic Predisposition to Disease, BRCA2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
